A. Torres

发表

Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.

C. Alonso, T. Ramón Y Cajal, J. Balmaña, 2008, Human reproduction.

Identification of a novel pathogenic mutation in BRCA2 in a Spanish breast-ovarian cancer family.

J. Brunet, J. Borràs, J. Gumà, 2009, Genetic testing and molecular biomarkers.

Risk factors associated with the occurrence of breast cancer after bilateral salpingo-oophorectomy in high-risk women.

T. Ramón Y Cajal, David Fisas, M. Baiget, 2011, Cancer epidemiology.

Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry

C. Alonso, T. Ramón Y Cajal, O. Díez, 2011, Breast Cancer Research and Treatment.

Large genomic rearrangements in mutation‐negative BRCA families: a population‐based study

J. Borràs, J. Gumà, A. Torres, 2010, Clinical genetics.

Comprehensive functional assessment of MLH1 variants of unknown significance

C. Lázaro, G. Capellá, T. Ramón Y Cajal, 2012, Human mutation.

MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families.

N. Rosenberg, S. Gruber, M. Urioste, 2010, Cancer research.

CAN-10-0570 Cancer esearch ical Studies 1 Founder Mutations with Moderate Penetrance in R nish Lynch Syndrome Families

N. Rosenberg, S. Gruber, V. Moreno, 2010 .

ATM germline mutations in Spanish early‐onset breast cancer patients negative for BRCA1/BRCA2 mutations

S. Sanjosé, J. Menéndez, S. Gutiérrez‐Enríquez, 2008, Clinical genetics.

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain

T. Ramón Y Cajal, J. Balmaña, J. Brunet, 2010, Familial Cancer.

Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

J. Benítez, I. Chirivella, Á. Carracedo, 2012, Breast Cancer Research and Treatment.

Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

J. Benítez, Á. Carracedo, J. Brunet, 2013, PloS one.

What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?

T. Ramón Y Cajal, J. Balmaña, J. Brunet, 2012, Breast.

Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis.

V. Moreno, J. Valls, G. Capellá, 2008, Gastroenterology.

Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer.

M. Benito, A. Díaz-López, J. Balibrea, 2005, Oncology reports.

p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.

M. Benito, J. Balibrea, A. Torres, 1997, British Journal of Cancer.

Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis.

V. Moreno, J. Valls, G. Capellá, 2008, Gastroenterology.

Two-field radical lymphadenectomy in the treatment of esophageal carcinoma.

O. G. Lopez, J. Balibrea, A. Sánchez-Pernaute, 1999, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families.

N. Rosenberg, S. Gruber, M. Urioste, 2010, Cancer research.